List of Tables
Table 1. Global Oncology Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Immunotherapy (Biologic Therapy)
Table 5. Key Players of Hormonal Therapy
Table 6. Key Players of Others
Table 7. Global Oncology Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Oncology Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Oncology Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Oncology Drugs Market Share by Region (2018-2023)
Table 11. Global Oncology Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Oncology Drugs Market Share by Region (2024-2029)
Table 13. Oncology Drugs Market Trends
Table 14. Oncology Drugs Market Drivers
Table 15. Oncology Drugs Market Challenges
Table 16. Oncology Drugs Market Restraints
Table 17. Global Oncology Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Oncology Drugs Market Share by Players (2018-2023)
Table 19. Global Top Oncology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Drugs as of 2022)
Table 20. Ranking of Global Top Oncology Drugs Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Oncology Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Oncology Drugs Product Solution and Service
Table 24. Date of Enter into Oncology Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oncology Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Oncology Drugs Revenue Market Share by Type (2018-2023)
Table 28. Global Oncology Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Oncology Drugs Revenue Market Share by Type (2024-2029)
Table 30. Global Oncology Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Oncology Drugs Revenue Market Share by Application (2018-2023)
Table 32. Global Oncology Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Oncology Drugs Revenue Market Share by Application (2024-2029)
Table 34. North America Oncology Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Oncology Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Oncology Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Oncology Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Oncology Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Oncology Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Oncology Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Oncology Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Oncology Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Oncology Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Oncology Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Oncology Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Oncology Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Oncology Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Oncology Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 49. Roche Company Detail
Table 50. Roche Business Overview
Table 51. Roche Oncology Drugs Product
Table 52. Roche Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
Table 53. Roche Recent Development
Table 54. Celgene Company Detail
Table 55. Celgene Business Overview
Table 56. Celgene Oncology Drugs Product
Table 57. Celgene Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
Table 58. Celgene Recent Development
Table 59. Novartis Company Detail
Table 60. Novartis Business Overview
Table 61. Novartis Oncology Drugs Product
Table 62. Novartis Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Bristol-Myers Squibb Company Detail
Table 65. Bristol-Myers Squibb Business Overview
Table 66. Bristol-Myers Squibb Oncology Drugs Product
Table 67. Bristol-Myers Squibb Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
Table 68. Bristol-Myers Squibb Recent Development
Table 69. Johnson & Johnson Company Detail
Table 70. Johnson & Johnson Business Overview
Table 71. Johnson & Johnson Oncology Drugs Product
Table 72. Johnson & Johnson Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
Table 73. Johnson & Johnson Recent Development
Table 74. Merck & Co. Company Detail
Table 75. Merck & Co. Business Overview
Table 76. Merck & Co. Oncology Drugs Product
Table 77. Merck & Co. Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
Table 78. Merck & Co. Recent Development
Table 79. AstraZeneca Company Detail
Table 80. AstraZeneca Business Overview
Table 81. AstraZeneca Oncology Drugs Product
Table 82. AstraZeneca Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
Table 83. AstraZeneca Recent Development
Table 84. Pfizer Company Detail
Table 85. Pfizer Business Overview
Table 86. Pfizer Oncology Drugs Product
Table 87. Pfizer Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
Table 88. Pfizer Recent Development
Table 89. Amgen Company Detail
Table 90. Amgen Business Overview
Table 91. Amgen Oncology Drugs Product
Table 92. Amgen Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
Table 93. Amgen Recent Development
Table 94. Eli Lilly Company Detail
Table 95. Eli Lilly Business Overview
Table 96. Eli Lilly Oncology Drugs Product
Table 97. Eli Lilly Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
Table 98. Eli Lilly Recent Development
Table 99. AbbVie Company Detail
Table 100. AbbVie Business Overview
Table 101. AbbVie Oncology Drugs Product
Table 102. AbbVie Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
Table 103. AbbVie Recent Development
Table 104. Takeda Company Detail
Table 105. Takeda Business Overview
Table 106. Takeda Oncology Drugs Product
Table 107. Takeda Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
Table 108. Takeda Recent Development
Table 109. Astellas Company Detail
Table 110. Astellas Business Overview
Table 111. Astellas Oncology Drugs Product
Table 112. Astellas Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
Table 113. Astellas Recent Development
Table 114. Ipsen Company Detail
Table 115. Ipsen Business Overview
Table 116. Ipsen Oncology Drugs Product
Table 117. Ipsen Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
Table 118. Ipsen Recent Development
Table 119. Sanofi Company Detail
Table 120. Sanofi Business Overview
Table 121. Sanofi Oncology Drugs Product
Table 122. Sanofi Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
Table 123. Sanofi Recent Development
Table 124. Bayer Company Detail
Table 125. Bayer Business Overview
Table 126. Bayer Oncology Drugs Product
Table 127. Bayer Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
Table 128. Bayer Recent Development
Table 129. Biogen Idec Company Detail
Table 130. Biogen Idec Business Overview
Table 131. Biogen Idec Oncology Drugs Product
Table 132. Biogen Idec Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
Table 133. Biogen Idec Recent Development
Table 134. Teva Company Detail
Table 135. Teva Business Overview
Table 136. Teva Oncology Drugs Product
Table 137. Teva Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
Table 138. Teva Recent Development
Table 139. Otsuka Company Detail
Table 140. Otsuka Business Overview
Table 141. Otsuka Oncology Drugs Product
Table 142. Otsuka Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
Table 143. Otsuka Recent Development
Table 144. Eisai Company Detail
Table 145. Eisai Business Overview
Table 146. Eisai Oncology Drugs Product
Table 147. Eisai Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
Table 148. Eisai Recent Development
Table 149. Merck KGaA Company Detail
Table 150. Merck KGaA Business Overview
Table 151. Merck KGaA Oncology Drugs Product
Table 152. Merck KGaA Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
Table 153. Merck KGaA Recent Development
Table 154. Gilead Sciences Company Detail
Table 155. Gilead Sciences Business Overview
Table 156. Gilead Sciences Oncology Drugs Product
Table 157. Gilead Sciences Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
Table 158. Gilead Sciences Recent Development
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Oncology Drugs Market Share by Type: 2022 VS 2029
Figure 3. Chemotherapy Features
Figure 4. Targeted Therapy Features
Figure 5. Immunotherapy (Biologic Therapy) Features
Figure 6. Hormonal Therapy Features
Figure 7. Others Features
Figure 8. Global Oncology Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Oncology Drugs Market Share by Application: 2022 VS 2029
Figure 10. Blood Cancer Case Studies
Figure 11. Breast Cancer Case Studies
Figure 12. Gastrointestinal Cancer Case Studies
Figure 13. Prostate Cancer Case Studies
Figure 14. Respiratory or Lung Cancer Case Studies
Figure 15. Others Case Studies
Figure 16. Oncology Drugs Report Years Considered
Figure 17. Global Oncology Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 18. Global Oncology Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Oncology Drugs Market Share by Region: 2022 VS 2029
Figure 20. Global Oncology Drugs Market Share by Players in 2022
Figure 21. Global Top Oncology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Drugs as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Oncology Drugs Revenue in 2022
Figure 23. North America Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Oncology Drugs Market Share by Country (2018-2029)
Figure 25. United States Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Oncology Drugs Market Share by Country (2018-2029)
Figure 29. Germany Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Oncology Drugs Market Share by Region (2018-2029)
Figure 37. China Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Oncology Drugs Market Share by Country (2018-2029)
Figure 45. Mexico Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Oncology Drugs Market Share by Country (2018-2029)
Figure 49. Turkey Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Oncology Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Roche Revenue Growth Rate in Oncology Drugs Business (2018-2023)
Figure 52. Celgene Revenue Growth Rate in Oncology Drugs Business (2018-2023)
Figure 53. Novartis Revenue Growth Rate in Oncology Drugs Business (2018-2023)
Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Oncology Drugs Business (2018-2023)
Figure 55. Johnson & Johnson Revenue Growth Rate in Oncology Drugs Business (2018-2023)
Figure 56. Merck & Co. Revenue Growth Rate in Oncology Drugs Business (2018-2023)
Figure 57. AstraZeneca Revenue Growth Rate in Oncology Drugs Business (2018-2023)
Figure 58. Pfizer Revenue Growth Rate in Oncology Drugs Business (2018-2023)
Figure 59. Amgen Revenue Growth Rate in Oncology Drugs Business (2018-2023)
Figure 60. Eli Lilly Revenue Growth Rate in Oncology Drugs Business (2018-2023)
Figure 61. AbbVie Revenue Growth Rate in Oncology Drugs Business (2018-2023)
Figure 62. Takeda Revenue Growth Rate in Oncology Drugs Business (2018-2023)
Figure 63. Astellas Revenue Growth Rate in Oncology Drugs Business (2018-2023)
Figure 64. Ipsen Revenue Growth Rate in Oncology Drugs Business (2018-2023)
Figure 65. Sanofi Revenue Growth Rate in Oncology Drugs Business (2018-2023)
Figure 66. Bayer Revenue Growth Rate in Oncology Drugs Business (2018-2023)
Figure 67. Biogen Idec Revenue Growth Rate in Oncology Drugs Business (2018-2023)
Figure 68. Teva Revenue Growth Rate in Oncology Drugs Business (2018-2023)
Figure 69. Otsuka Revenue Growth Rate in Oncology Drugs Business (2018-2023)
Figure 70. Eisai Revenue Growth Rate in Oncology Drugs Business (2018-2023)
Figure 71. Merck KGaA Revenue Growth Rate in Oncology Drugs Business (2018-2023)
Figure 72. Gilead Sciences Revenue Growth Rate in Oncology Drugs Business (2018-2023)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed